Physiomics ‘Healthiest Ever’ Pipeline and £540k Contract Wins as New Board Targets Higher Valuation

StockBox

10.8K subscribers

ShareSubscribe

Physiomics ‘Healthiest Ever’ Pipeline and £540k Contract Wins as New Board Targets Higher Valuation StockBox speaks with Jesse Thissen, COO of Physiomics, and Mike Whitlow, Executive Director, to discuss the company’s growing commercial pipeline, operational changes and ambitions to deliver sustainable profitability. Jesse explains how Physiomics supports pharmaceutical and biotech companies through mathematical modelling, biostatistics and data management, helping clients make better decisions throughout clinical development. Mike discusses the refreshed board’s commercial strategy, recent technology and infrastructure upgrades, increased director share ownership and the opportunity to secure larger contracts. With management describing the current pipeline as the strongest in Physiomics’ history, the company is focused on building on approximately £540,000 of recently introduced contracts and progressing towards break-even and its first profit. Key topics discussed: Physiomics’ Modelling & Simulation services Biostatistics, Biometrics and data management Strong growth in the commercial pipeline Approximately £540,000 of contracts Attracting larger clients and contracts Recruitment to support growing demand Technology and infrastructure upgrades The pathway to break-even and profitability Director share ownership and shareholder alignment Building a stronger commercial culture 👍 Like this interview and subscribe to StockBoxMedia for more company updates and investor interviews. 🔗 Watch the latest Research Talks video: https://www.youtube.com/watch?v=XQlGbnmsfgc 🌐 Visit StockBox Media: https://stockboxmedia.com/ 🏢 Visit the company website: https://www.physiomics.co.uk/ 📰 Sign up for the StockBox Media newsletter: https://mailchi.mp/stockboxmedia.com/zhf1vui0io 🐦 Follow StockBox Media on X: https://x.com/StockBoxMedia